Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05425940
Title Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer (STELLAR-303)
Acronym STELLAR-303
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Exelixis
Age Groups: senior | adult
Covered Countries USA | NZL | GBR | FRA | ESP | DEU | BEL | AUS

Additional content available in CKB BOOST